These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23702802)

  • 21. Sedation in acute and chronic agitation.
    Levy RH
    Pharmacotherapy; 1996; 16(6 Pt 2):152S-159S; discussion 166S-168S. PubMed ID: 8947999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First-episode schizophrenia: the importance of early intervention and subjective tolerability.
    Kasper S
    J Clin Psychiatry; 1999; 60 Suppl 23():5-9. PubMed ID: 10625193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological management of acutely agitated schizophrenic patients.
    San L; Arranz B; Escobar R
    Curr Pharm Des; 2005; 11(19):2471-7. PubMed ID: 16026300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Algorithm for treatment-refractory schizophrenia.
    Koshino Y
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S9-13. PubMed ID: 10560891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia.
    Fang M; Chen H; Li LH; Wu R; Li Y; Liu L; Ye M; Huang J; Zhu S; Wang G; Zhang Q; Zheng H; Zhang L; Wang B; Zhou J; Zhao JP
    Int Clin Psychopharmacol; 2012 Mar; 27(2):107-13. PubMed ID: 22233697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment-resistant schizophrenia - biological treatments].
    Hasan A; Wobrock T
    Fortschr Neurol Psychiatr; 2013 Aug; 81(8):464-71; quiz 472. PubMed ID: 23939560
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.
    Gaebel W; Möller HJ; Buchkremer G; Ohmann C; Riesbeck M; Wölwer W; Von Wilmsdorff M; Bottlender R; Klingberg S
    Eur Arch Psychiatry Clin Neurosci; 2004 Apr; 254(2):129-40. PubMed ID: 15146342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of neuroleptic-induced akathisia with propranolol: a controlled replication study.
    Kramer MS; Gorkin R; DiJohnson C
    Hillside J Clin Psychiatry; 1989; 11(2):107-19. PubMed ID: 2577308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia.
    Gaebel W; Riesbeck M; Wölwer W; Klimke A; Eickhoff M; von Wilmsdorff M; Lemke M; Heuser I; Maier W; Huff W; Schmitt A; Sauer H; Riedel M; Klingberg S; Köpcke W; Ohmann C; Möller HJ;
    J Clin Psychiatry; 2011 Feb; 72(2):205-18. PubMed ID: 20673559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Old drug in new package promises to calm the agitated.
    Morrow T
    Manag Care; 2014 Apr; 23(4):50-1. PubMed ID: 24864536
    [No Abstract]   [Full Text] [Related]  

  • 31. Factors which can make patients difficult to treat.
    Kane JM
    Br J Psychiatry Suppl; 1996 Dec; (31):10-4. PubMed ID: 8968650
    [No Abstract]   [Full Text] [Related]  

  • 32. Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns.
    Apiquian R; Fresán A; de la Fuente-Sandoval C; Ulloa RE; Nicolini H
    BMC Psychiatry; 2004 Apr; 4():12. PubMed ID: 15109398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iloperidone for the treatment of schizophrenia: an updated clinical review.
    Weiden PJ
    Clin Schizophr Relat Psychoses; 2012 Apr; 6(1):34-44. PubMed ID: 22453868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [From neuroleptics toward antipsychotics: practice of changing the treatment, choice of the time and disputes, clinical aspects].
    Plas J
    Encephale; 2003 Sep; 29(Pt 2):S40-2. PubMed ID: 14710536
    [No Abstract]   [Full Text] [Related]  

  • 35. Choice of maintenance medication for schizophrenia.
    Davis JM; Chen N
    J Clin Psychiatry; 2003; 64 Suppl 16():24-33. PubMed ID: 14680416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Expert Consensus Guideline Series. Treatment of behavioral emergencies.
    Allen MH; Currier GW; Hughes DH; Reyes-Harde M; Docherty JP;
    Postgrad Med; 2001 May; (Spec No):1-88; quiz 89-90. PubMed ID: 11500996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
    Johnson DA
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concomitant psychotropic medication use during treatment of schizophrenia patients: longitudinal results from the CATIE study.
    Chakos M; Patel JK; Rosenheck R; Glick ID; Hammer MB; Tapp A; Miller A; Miller D
    Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):124-34. PubMed ID: 21983496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The problem of drug compliance in schizophrenic patients].
    Albus M
    Psychiatr Prax; 1995 Nov; 22(6):221-2. PubMed ID: 8570750
    [No Abstract]   [Full Text] [Related]  

  • 40. Combination therapy in the treatment of schizophrenia.
    Wolff-Menzler C; Hasan A; Malchow B; Falkai P; Wobrock T
    Pharmacopsychiatry; 2010 Jun; 43(4):122-9. PubMed ID: 20309809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.